Scott WilliamsNuclear MedicineTumor ImagingNeotect (Tc99-m-Depreotide) (P-829)Scott WilliamsApr 2, 2002 Neotect (Tc99-m-Depreotide) (P-829) Clinical Chemistry and pharmacology Patient Instructions Imaging Protocol Interpretation Indications for the exam Dosimetry Complications/Side Effects HAMA Formation (Immunogenicity) Latest in Tumor ImagingTumor > Therapy > Xofigo and other Prostate AgentsAugust 16, 2017Tumor > Therapy > Xofigo and PSMA therapiesJanuary 26, 2015SponsoredFREE WEBINAR: Advanced visualization in 2024: Enhancing radiology careApril 17, 2024Tumor > Therapy > MicrospheresJanuary 31, 2008Related StoriesTumor ImagingThallium Tumor Imaging:Tumor ImagingIntroductionTumor ImagingTumor > CEA-scan > Cytogen casesSponsor ContentRegister today for a FREE webinar May 8 at 12 Noon EDT